Home / Strategic Advisory Board

Strategic Advisory Board

Strategic Advisory Board|

Guiding Strategy, Innovation, and Growth Through Expert External Insights

Talk to Our TeamTalk to Our Team

Who We Are

Indegene's Strategic Advisory Board (SAB) brings together external industry leaders to provide independent perspective, domain expertise, and forward-looking insights to support the company's next phase of growth. The SAB advises the executive team on strategic priorities, emerging industry trends, and partnerships to strengthen innovation, performance, and market positioning.

Members

Jill De Simone

Ex Merck, Head of US Oncology; Former BMS, Teva

Amgen Board Member

Adele Gulfo

Corporate Board Director; Former President, Primary Care, Pfizer; Former CEO, Biopharma Commercial

Sumitomo

Aida Habtezion

Former CMO, SVP and Head of Worldwide Medical and Safety

Pfizer

Anthony Mancini

Chief Global Commercialization Officer

Revolution Medicines

Dave Lennon

CEO & President

Whitehawk Therapeutics

John Shamsey

President

Evoke Navience

Juanjo Francesch

CIO

Merck Animal Health

Suneet Varma

CEO Intent Biologics; Former Global Oncology & US President

Pfizer

Michelle Keefe

Former Chief Executive Officer

Syneos Health

Alok Sonig

Chief Executive Officer

Rosemont Pharmaceuticals

Solutions

Strategy & Consulting Clinical Development Regulatory Affairs Pharmacovigilance Medical Affairs Launch Excellence AI Content Operations Campaign Operations

Solutions

AI Search Optimization Lifecycle Optimization Market Access & Pricing Patient Services Technology Services Data, Analytics & AI Global Capability Centers Enterprise Operations

Platform

Platforms & AI Cortex Platform Next Technology Accelerators

Investors

Investor Relations

Company

Our Story Leadership Recognition Social Responsibility ESG / Sustainability Careers Contact Us

© 2026 Indegene — All rights reserved

Policies Indegene Speak Up CookiesAccessibility Statement